Nykvarn, Sweden

Edib Jakupovic


Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 227(Granted Patents)


Company Filing History:


Years Active: 1990-2001

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Edib Jakupovic: Innovator in Pharmaceutical Engineering

Introduction

Edib Jakupovic is a notable inventor based in Nykvarn, Sweden. He has made significant contributions to the field of pharmaceutical engineering, particularly in the development of processes for inhalation therapies. With a total of 11 patents to his name, Jakupovic has established himself as a key figure in the innovation of respiratory medications.

Latest Patents

One of his latest patents is titled "Process for the preparation of respirable particles." This innovative process involves producing a pharmaceutical powder for inhalation that comprises crystalline particles of an inhalation compound. The method includes dissolving the inhalation compound in a solvent and introducing the solution in droplet form or as a jet stream into an anti-solvent that is miscible with the solvent and under agitation. Another significant patent involves the "Forms of organic salts of N,N'-diacetylcystine," which further showcases his expertise in pharmaceutical formulations.

Career Highlights

Throughout his career, Edib Jakupovic has worked with prominent companies in the pharmaceutical industry, including Astra Aktiebolag and Aktiebolaget Astra. His work has focused on enhancing the efficacy and delivery of inhalation therapies, which are crucial for patients with respiratory conditions.

Collaborations

Jakupovic has collaborated with several professionals in his field, including Eric Nils Teneberg and Jan W Trofast. These collaborations have contributed to the advancement of his research and the successful development of his patented processes.

Conclusion

Edib Jakupovic's contributions to pharmaceutical engineering, particularly in inhalation therapies, highlight his innovative spirit and dedication to improving patient care. His patents reflect a commitment to advancing medical technology and enhancing the effectiveness of respiratory treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…